Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Part VII Transfer

14 Nov 2025 11:00

RNS Number : 4976H
Clydesdale Bank PLC
14 November 2025
 

CLYDESDALE BANK PLC

LEI: NHXOBHMY8K53VRC7MZ54

Application for transfer of banking business under Part VII of the Financial Services and Markets Act 2000

Clydesdale Bank PLC (trading as Virgin Money) ("CB") announces that on 3 November 2025, CB and Nationwide Building Society ("NBS") made an application (the "Application") to the High Court of Justice for an Order under section 111(1) of the Financial Services and Markets Act 2000 (as amended) sanctioning a banking business transfer scheme (the "Scheme") providing for the transfer to NBS of the Transferring Business (as defined in the document setting out the terms of the Scheme (the "Scheme Document")).

The Transferring Business consists of the entire business of CB (with the exception of a small number of products, contracts and arrangements, which constitute the Excluded Business (as defined in the Scheme Document)).

The proposed transfer will result in the Transferring Business, which is currently being carried on by CB, being carried on by NBS.

A copy of the Scheme Document, an explanatory statement setting out the terms of the Scheme and a formal notice of the transfer will be sent free of charge to any person who requests it using the contact details set out below. These documents are available to collect from 177 Bothwell Street, Glasgow, Scotland, G2 7ER until the date on which the Application is heard by the Court.

These and other documents relating to the Scheme are also available on CB's website at www.virginmoney.com/nationwide-transfer. This website will be updated with any key changes in respect of the Scheme.

All questions or concerns and any requests for information relating to the Scheme should be referred to CB by email to: treasury-virginmoney-transfer@nationwide.co.uk (for Treasury counterparties) or nationwide-transfer@virginmoney.com (for customers and other interested parties). In relation to the Scheme, CB can also be contacted by telephone on 0800 066 5008* (or 00 44 141 880 2050** from outside of the UK) from 8am to 6pm, Monday to Friday and 9am to 3pm on Saturdays, or by post at:

Nationwide TransferThe team at Virgin MoneySunderlandSR43 4JB

The Application is due to be heard before the Court on 23 February 2026. If approved by the Court, it is currently proposed that the Scheme will take effect on 2 April 2026.

Any person that wishes to object to the Scheme may contact CB (who will share a copy of their objection with the Court), attend the Court hearing in person, or appoint a representative to attend the Court hearing on their behalf.

It would be helpful if anyone planning to object could let CB know before 9 February 2026. Any changes to the date of the hearing and any details required to attend the hearing will then be communicated to any such person by CB. CB will also try to address any of the concerns raised before the hearing. CB will reply to all objections and will submit copies of any objections it receives to the Court, as well as to the Prudential Regulation Authority and the Financial Conduct Authority.

14 November 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDBRGBDGUX
Date   Source Headline
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus
16th Dec 202010:33 amRNSPublication of Final Terms
8th Dec 202012:47 pmRNSHolding(s) in Company
8th Dec 202012:46 pmRNSInitial admission - Offcl Lst
1st Dec 202012:17 pmRNSIssue of Equity
20th Nov 20204:08 pmRNSPublication of Suppl.Prospcts
20th Nov 20207:00 amRNSHalf-year Report
30th Oct 20201:46 pmRNSPublication of a Prospectus
18th Sep 20202:57 pmRNSResults of Tender Offers
18th Sep 202010:04 amRNSIndicative Results of Tender Offers
10th Sep 202011:24 amRNSTender Offer
1st Sep 202012:00 pmRNSDirectorate Change
27th Aug 20201:41 pmRNSPublication of Final Terms
21st Jul 20207:00 amRNSPublication of Final Terms
16th Jul 20201:35 pmRNSResult of AGM
10th Jul 20201:23 pmRNSPublication of Suppl.Prospcts
18th Jun 202010:11 amRNSInitial admission - Offcl Lst
17th Jun 20201:00 pmRNSHolding(s) in Company
15th Jun 202012:20 pmRNSPublication of a Prospectus
10th Jun 20208:32 amRNSIssue of Equity
29th May 20207:00 amRNSAnnual Financial Report
3rd Apr 20207:00 amRNSNationwide for Business
10th Mar 20207:00 amRNSDirectorate Change
13th Feb 20203:30 pmRNSPublication of Final Terms
6th Feb 20204:03 pmRNSPublication of a Prospectus
27th Jan 202011:30 amRNSPublication of Final Terms
22nd Jan 20203:00 pmRNSPublication of Final Terms
22nd Jan 20207:00 amRNSNotice to Bondholders
20th Jan 20201:00 pmRNSAppointment of Senior Independent Director
16th Dec 20195:49 pmRNSResponse to Results of BOE Stress Test 2019
25th Nov 20191:33 pmRNSPublication of Suppl.Prospcts
22nd Nov 20197:00 amRNSHalf-year Report
7th Nov 20192:04 pmRNSNotice of Pricing Results
7th Nov 20199:55 amRNSNotice of Results of Bondholder Meeting
4th Nov 201911:10 amRNSPublication of a Prospectus
16th Oct 201910:43 amRNSNotice to Bondholders
20th Sep 20195:12 pmRNSPublication of Offering Circular
13th Sep 20197:00 amRNSUpdate on Payment Protection Insurance
2nd Sep 20197:00 amRNSNon Executive Director Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.